Cellectar Biosciences Statistics

Total Valuation

CLRB has a market cap or net worth of $13.46 million. The enterprise value is -$8.27 million.

Market Cap	13.46M
Enterprise Value	-8.27M

Important Dates

The last earnings date was Thursday, March 13, 2025, before market open.

Earnings Date	Mar 13, 2025
Ex-Dividend Date	n/a

Share Statistics

CLRB has 46.08 million shares outstanding. The number of shares has increased by 203.92% in one year.

Current Share Class	46.08M
Shares Outstanding	46.08M
Shares Change (YoY)	+203.92%
Shares Change (QoQ)	+5.39%
Owned by Insiders (%)	1.64%
Owned by Institutions (%)	13.03%
Float	45.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.05
P/TBV Ratio	1.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.58, with a Debt / Equity ratio of 0.03.

Current Ratio	2.58
Quick Ratio	2.48
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -4,693.38% and return on invested capital (ROIC) is -2,196.39%.

Return on Equity (ROE)	-4,693.38%
Return on Assets (ROA)	-172.36%
Return on Invested Capital (ROIC)	-2,196.39%
Return on Capital Employed (ROCE)	-321.87%
Revenue Per Employee	n/a
Profits Per Employee	-$4.05M
Employee Count	11
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, CLRB has paid $66,000 in taxes.

Income Tax	66,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.16% in the last 52 weeks. The beta is 0.96, so CLRB's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	-92.16%
50-Day Moving Average	0.30
200-Day Moving Average	1.44
Relative Strength Index (RSI)	43.01
Average Volume (20 Days)	1,497,482

Short Selling Information

The latest short interest is 2.92 million, so 6.34% of the outstanding shares have been sold short.

Short Interest	2.92M
Short Previous Month	1.97M
Short % of Shares Out	6.34%
Short % of Float	6.45%
Short Ratio (days to cover)	2.15

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-51.78M
Pretax Income	-51.04M
Net Income	-44.58M
EBITDA	-51.49M
EBIT	-51.78M
Earnings Per Share (EPS)	-$1.40

Full Income Statement

Balance Sheet

The company has $23.29 million in cash and $494,003 in debt, giving a net cash position of $22.79 million or $0.49 per share.

Cash & Cash Equivalents	23.29M
Total Debt	494,003
Net Cash	22.79M
Net Cash Per Share	$0.49
Equity (Book Value)	15.68M
Book Value Per Share	0.30
Working Capital	14.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$47.58 million and capital expenditures -$104,195, giving a free cash flow of -$47.69 million.

Operating Cash Flow	-47.58M
Capital Expenditures	-104,195
Free Cash Flow	-47.69M
FCF Per Share	-$1.03

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLRB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-203.92%
Shareholder Yield	n/a
Earnings Yield	-306.84%
FCF Yield	-328.22%

Analyst Forecast

The average price target for CLRB is $28.00, which is 9,489.04% higher than the current price. The consensus rating is "Buy".

Price Target	$28.00
Price Target Difference	9,489.04%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-30.62%

Stock Forecasts

Stock Splits

The last stock split was on July 22, 2022. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jul 22, 2022
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1